Tag: vaccine

Business Insider’s guide to vaccine results

Hello,



Hollis Johnson/Business Insider


© Hollis Johnson/Business Insider
Hollis Johnson/Business Insider

Hope you all had good weeks! I celebrated the eighth birthday of my dog, Junior. (Photos here of him with his present, because we could all use more dog photos in our lives these days). 

I also spent time reflecting on Tuesday’s news that the pandemic has killed at least 200,000 people in the US.

Reporter Jose Pagliery on Twitter reminded me of where that stacks up with the initial projections hospitals were using way back in February. At the time, one expert’s best guess was that there would be 96 million cases in the US and 480,000 deaths. Reading those estimates at the time provided some gravity to what was about to hit the US.  

Roughly seven months from when that presentation was given, we’re at 200,000 deaths and 7 million confirmed cases in the US. 

Before I get

Read More

Coronavirus vaccine: Moderna, J&J plan pediatric trials

So far, children have been left out of the race to create a coronavirus vaccine.

That’s not unusual. Drugmakers typically test drugs and vaccines first on adults, before moving to pediatric trials.

But it means that kids probably won’t be able to get the first coronavirus vaccines should they become available, creating a crucial gap in efforts to fight the pandemic. Drugmakers usually need to test a vaccine in children before seeking approval to give the shots to kids.

All four drugmakers who are furthest along in the coronavirus vaccine race told Business Insider that they eventually plan to start testing their shots in kids. But none of them provided an estimate on when a shot could be available for children.

SIGN UP NOW TO TUNE IN ON OCTOBER 5: Hear the latest on the race for a coronavirus vaccine and the ‘return to normal’ from 3 leading experts

If

Read More

FDA vaccine requirements; Sizzler files bankruptcy

Jessica Flores

Ryan W. Miller
 
| USA TODAY
play

Students in Miami-Dade County, Florida, will soon be allowed to go back to school. In person.

The Miami-Dade County School Board voted unanimously Tuesday to start a staggered reopening plan on Oct. 14 in the country’s fourth largest district, with all students back in classrooms by Oct. 21. The plan applies only to families who wish for their children to resume in-person instruction.

Also Tuesday, President Donald Trump said it was “a shame” that the U.S. death toll from COVID-19 had surpassed 200,000, the most of any country in the world.

Veteran journalist Bob Woodward sees it differently. He told CNN he was “quite frankly embarrassed”

Read More

Daily, Weekly & Monthly COVID-19 Vaccine Developments Direct to your Inbox

DUBLIN, Sept. 22, 2020 /PRNewswire/ –The “COVID-19 – Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances – Premium Bundle” report has been added to ResearchAndMarkets.com’s offering.

The COVID-19 – Vaccine Development, Therapeutics Experiments and Diagnostics/devices advances – Premium Bundle includes:

  • Subscription to 6 Dailies
  • Subscription to 6 Weekly Summary Reports
  • Subscription to 6 Monthly Synthesis Reports

Choices available to choose from:

Daily: 27 Daily reports available
To choose one Daily report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Weekly: 15 Weekly summary reports available
To choose one Weekly summary report from the available Categories, Regions, Healthcare sub-industries and Market capitalization levels

Monthly: 22 Monthly synthesis reports available
To choose one Monthly report from the available sub-categories within each of the three categories

Key Topics Covered:

Coverage – Daily Reports:

  • Daily report offer at five different time zones, daily updates for 20+ global news each related to
Read More

No sign of US, China as global vaccine plan gathers momentum | Coronavirus pandemic News

An initiative to ensure any future vaccine against COVID-19 is fairly shared throughout the world has secured the backing of 156 countries and territories, representing about 64 percent of the global population, but the United States and China have yet to sign up.

The COVID-19 Vaccines Global Access Facility (COVAX) is being led by the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI) and Gavi, the Vaccine Alliance and aims to deliver some two billion vaccine doses around the world by the end of next year. 

“COVAX is now in business: governments from every continent have chosen to work together, not only to secure vaccines for their own populations, but also to help ensure that vaccines are available to the most vulnerable everywhere,” Gavi CEO Dr Seth Berkley said in a statement.

“With the commitments we’re announcing today for the COVAX Facility, as well as the historic

Read More

2 Cheap Stocks to Buy Before the COVID-19 Vaccine

At the risk of sounding too optimistic, it is highly likely that humans will find a way to deal with COVID-19. There are, however, certain sectors of the economy, like retail-focused real estate investment trusts (REITs), that are taking it on the chin right now because of the pandemic. But if you pick financially strong businesses that can muddle through until science provides the world with an effective vaccine, you might find that you’ve picked up some great stocks on the cheap.

Here are two stocks to consider right now, before there’s a COVID-19 vaccine.

1. It’s not that ugly anymore

After decades of annual dividend increases through good markets and bad, Tanger Factory Outlet Center (NYSE:SKT) suspended its dividend in early 2020. Although it was in strong financial shape, it also tapped virtually all of its outstanding credit line to ensure it had the liquidity it needed to get

Read More

Today’s Logistics Report: Planning Vaccine Delivery; Germany’s Export Cloud; Assembling Ford Trucks

Plans for distributing a Covid-19 vaccine remain a work in progress as the shots move closer to approval. State officials and medical-supply experts say critical issues weren’t resolved in the federal government’s release of two vaccine-distribution plans this week. The WSJ’s Peter Loftus and Jared S. Hopkins report the slow ramp-up for a distribution strategy could hamper efforts to get doses quickly to health-care workers and others at high risk of infection. Some states might not initially get all of the supplies they were expecting, or have the freezer capacity needed to safely store their drug allocation.

Transportation and logistics companies have been preparing for the potential sudden rush to distribute doses through temperature-controlled networks with little margin for error. The federal program through Operation Warp Speed sketches out distribution of any vaccine that regulators authorize for use, including starting shipments within 24 hours of the green light. But medical

Read More

Texas, Las Vegas restrictions; Moderna vaccine trial

CLOSE

Without masks and a vaccine, we could reach Herd Immunity from COVID-19, but deaths would skyrocket. We break down the science of it.

USA TODAY

With the U.S. approaching 200,000 confirmed COVID-19 deaths and worldwide infections topping 30 million, Texas and Nevada are set to ease restrictions for some businesses beginning this weekend.

In Texas, which is close to becoming the second state with 700,000 cases, Gov. Greg Abbott is authorizing some businesses — including restaurants, retail stores, gyms and museums — to open up to 75% capacity starting Monday. Bars, however, must remain closed.

In Nevada, public health officials are allowing bars in and around Las Vegas to reopen on Sunday after being closed for six months.

Meanwhile, India is on track to pass the U.S. as the most infected country in the world. Health officials on Friday reported another 96,000 cases in the past 24 hours, pushing

Read More

Business leaders ask for inclusivity after vaccine nationalism warning

Small bottles labeled with a “Vaccine COVID-19” sticker and a medical syringe are seen in this illustration taken taken April 10, 2020.

Dado Ruvic | Reuters

Business leaders have called on nations to be more inclusive when thinking about how they can reboot their economies following the coronavirus pandemic.

Speaking at a CNBC-moderated panel at the Singapore Summit on Monday, Kiran Mazumdar-Shaw, executive chairman of Indian biopharmaceutical firm Biocon, said that “vaccine nationalism is creeping into the world,” with some countries eager to snap up the first stock of any approved vaccines.

It’s “very sad” when countries don’t realize this is a pandemic that has affected the entire world, she said, adding that sending vaccines to where they’re needed should be a global effort.

“People have to be less worried about the kind of trade wars they’re fighting right now, and realize there is something in it for everyone,” Mazumdar-Shaw

Read More

Global Veterinary Vaccine Market 2020 Business Outlook with COVID-19 Scenario to 2025

The MarketWatch News Department was not involved in the creation of this content.

Sep 13, 2020 (CDN Newswire via Comtex) —
MarketsandResearch.biz has announced a new market research study titled Global Veterinary Vaccine Market 2020 by Manufacturers, Type and Application, Forecast to 2025 that covers industry environment, segmentation analysis, and competitive landscape and all these market aspects demonstrate a comprehensive analysis of the global market. The report presents a pin-point analysis of market share, size, trends, development plans, growth, driver’s analysis, investment plan, and cost structure. The report contains realistic concepts of the market simply and plainly. It investigates past progress, ongoing market scenarios, and gives prospects from 2020 to 2025. Key companies are profiled in this report based on Veterinary Vaccine business overview, financial data, product landscape, strategic outlook & analysis. Some of the major players operating in the global market are: Merck, Ringpu Biology, Boehringer Ingelheim, Zoetis, HVRI,

Read More